Medical Specialty Bags Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Ostomy Collection Bags, Intravenous (IV) Fluid Bags, Continuous Ambulatory Peritoneal Dialysis (CAPD) Bags, Resuscitation Bags, Urinary Collection Bags, Sterile Packaging Bags, Anesthesia Breathing Bags, Cadaver (Body) Bags, Blood Bags, Enema Bags, Enteral Feeding Bags, Bile Collection Bags, Ice Bags), By Region and Competition, 2021-2031F

Forecast Period	2027-2031
Market Size (2025)	USD 7.27 Billion
CAGR (2026-2031)	5.63%
Fastest Growing Segment	Ostomy Collection Bags
Largest Market	North America
Market Size (2031)	USD 10.11 Billion

Market Overview

The Global Medical Specialty Bags Market will grow from USD 7.27 Billion in 2025 to USD 10.11 Billion by 2031 at a 5.63% CAGR. Medical specialty bags are sterile containers designed for the collection, storage, and administration of bodily fluids, encompassing products such as ostomy pouches, blood storage units, and intravenous systems. The primary driver propelling market growth is the rising global incidence of chronic urinary and gastrointestinal disorders alongside an aging population that requires continuous critical care. Substantiating this high demand, according to the American Cancer Society, in 2025, approximately 84,870 new cases of bladder cancer are estimated to be diagnosed in the United States, directly fueling the requisite for urostomy solutions.

A significant challenge potentially impeding market expansion involves strict environmental regulations concerning the disposal of medical plastic waste. Governments worldwide are increasingly enforcing policies to limit disposable polyvinyl chloride products, compelling manufacturers to incur substantial costs developing sustainable and biodegradable alternatives. This regulatory pressure to transition away from economical traditional materials poses a financial hurdle that may slow production scalability and affect overall profit margins within the sector.

Key Market Drivers

The rising prevalence of chronic urological and gastrointestinal diseases serves as a primary engine for the global medical specialty bags market. As the global population ages, the incidence of conditions such as colorectal cancer, inflammatory bowel disease, and urinary incontinence increases, necessitating long-term reliance on ostomy pouches and catheter drainage systems. This demographic shift ensures a consistent and expanding patient base requiring high-quality, discreet, and skin-friendly collection solutions. Substantiating this trend, according to Coloplast, November 2024, in the 'Annual Report 2023/24', their Ostomy Care business segment achieved an organic growth rate of 7%, reflecting the persistent global necessity for effective chronic condition management products.

Simultaneously, a worldwide surge in surgical procedures and minimally invasive operations is critically amplifying the demand for blood storage, intravenous, and fluid management bags. Hospitals and ambulatory surgical centers increasingly rely on these sterile disposables to maintain fluid balance and ensure patient safety during complex interventions. According to the American Red Cross, August 2024, in the 'National Blood Shortage Appeal', more than a quarter of all blood products utilized annually are dedicated to critical care and emergency room scenarios, directly driving the consumption of specialized collection containers. Furthermore, illustrating the financial magnitude of this sector, according to Convatec Group, in 2024, the company reported a total revenue of $2.14 billion for the fiscal year 2023, driven by accelerating demand across its chronic care and infusion franchises.

Download Free Sample Report

Key Market Challenges

Strict environmental regulations concerning the disposal of medical plastic waste constitute a significant impediment to the growth of the Global Medical Specialty Bags Market. These bags, essential for ostomy care and blood storage, are predominantly manufactured from polyvinyl chloride (PVC) due to its cost-effectiveness and durability. However, as international bodies enforce rigorous policies to curb plastic pollution, manufacturers face mounting pressure to replace established PVC formulations with biodegradable or recyclable alternatives. This transition necessitates substantial capital expenditure on research and development, which diverts financial resources away from production scalability and market expansion efforts, directly eroding potential profit margins.

The magnitude of this issue is underscored by the sheer volume of material involved. According to the Healthcare Plastics Recycling Council, in 2024, the global volume of healthcare plastics was projected to reach 48 billion pounds by 2025, the majority of which currently ends up in landfills or incineration due to contamination risks. This extensive accumulation of waste drives the intensifying regulatory scrutiny that manufacturers must navigate. Consequently, the high costs associated with developing compliant, eco-friendly materials and meeting waste management standards force companies to increase product pricing or absorb losses, thereby slowing the overall revenue trajectory of the sector.

Key Market Trends

The Adoption of Multi-Chamber and Premixed Drug Delivery Formats is fundamentally altering the market by mitigating medication errors and streamlining clinical workflows. Hospitals are increasingly replacing traditional compounding methods with pre-filled, multi-compartment bags that separate unstable ingredients until the point of administration, thereby minimizing the risk of contamination and dosage inaccuracy. This shift towards value-added sterile packaging is necessitating significant industrial investment in manufacturing capabilities to meet the rigorous sterility standards required for these complex infusion systems. Highlighting the scale of this sector's expansion, according to B. Braun, March 2024, in the 'Annual Report 2023', the company recorded a 3.0% increase in group sales to €8.8 billion, with significant growth in its Hospital Care division driven by the rising global demand for IV solutions and single-use automated infusion systems.

Concurrently, the Development of User-Centric Designs for Home Healthcare is expanding the utility of specialty bags beyond acute care settings. As complex therapies migrate from hospitals to residential environments, manufacturers are engineering durable, intuitive containers that allow patients to safely administer parenteral nutrition and dialysis fluids without constant professional supervision. This transition demands high-performance materials that ensure medication stability during transport and storage, creating a specialized niche for high-margin, portable infusion solutions. Underscoring the economic intensification within this segment, according to ICU Medical, August 2024, in the 'Second Quarter 2024 Results', the company reported that revenue from its Consumables segment, which encompasses essential infusion therapy products, rose by 11% year-over-year to reach $261.8 million, reflecting the robust consumption of sterile medical disposables across expanding care networks.

Segmental Insights

The Ostomy Collection Bags segment identifies as the fastest-growing area within the Global Medical Specialty Bags Market. This growth is propelled by the rising global incidence of chronic conditions such as colorectal cancer, bladder cancer, and inflammatory bowel disease. These ailments often necessitate surgical procedures like colostomies and ileostomies, creating an essential need for external waste collection devices. Additionally, an aging global population further accelerates demand, as geriatric patients are disproportionately affected by these disorders. Insights from the World Health Organization regarding the increasing burden of these diseases validate the sustained reliance on these products for post-operative management.

Regional Insights

North America maintains a dominant position in the global medical specialty bags market primarily due to the rising prevalence of chronic diseases requiring surgical interventions and continuous management. The region benefits from a well-integrated healthcare infrastructure and robust reimbursement policies that facilitate widespread access to essential medical supplies. Additionally, the presence of established market participants ensures consistent product availability across the United States and Canada. Strict quality standards enforced by the US Food and Drug Administration further support market stability by ensuring the safety and reliability of these medical devices for patient care.

Recent Developments

• In July 2025, B. Braun Medical Inc. expanded its portfolio of essential medicines with the launch of new Heparin Sodium Injection products in the United States. These premixed formulations are delivered in the company’s proprietary EXCEL IV Containers, which are manufactured without polyvinyl chloride (PVC), DEHP, or natural rubber latex. This launch positioned the company as a leading provider of these critical anticoagulants in environmentally friendly packaging. The containers also feature enhanced 2D barcode technology to improve medication safety and workflow efficiency in hospitals, demonstrating the company's commitment to patient safety and sustainable manufacturing practices in the medical specialty bags market.
• In July 2024, Coloplast introduced Heylo, the world's first digital leakage notification system for ostomy care, in the United Kingdom. This breakthrough technology consists of a sensor layer that fits underneath the baseplate and connects to a smartphone application via Bluetooth. The system monitors the seal integrity and notifies the user of any potential leakage before it becomes a visible issue, thereby addressing the significant physical and mental burden of leakage anxiety. By providing real-time data and reassurance, the device allows individuals with a stoma to manage their condition more confidently and proactively, representing a significant advancement in personalized stoma care.
• In February 2024, Convatec launched the Esteem Body with Leak Defense portfolio, a new range of soft convexity ostomy solutions designed to address the needs of patients with varying body profiles. This innovative one-piece system features a proprietary leak defense mechanism that combines a secure adhesive seal with a flexible, body-conforming shape to reduce leakage risks. The product line includes drainable, closed-end, and urostomy pouches, offering eight different convex combinations to optimize fit and comfort. This launch aimed to improve the quality of life for ostomy patients by providing greater security and reducing skin complications associated with leakage.
• In January 2024, Baxter International announced the successful completion of the first phase of its intravenous (IV) bag recycling pilot program in the United States. Conducted in collaboration with Northwestern Medicine, this initiative demonstrated the feasibility of diverting polyvinyl chloride (PVC) IV bag waste from landfills to be repurposed into non-medical products such as industrial floor mats. The program, which is the first of its kind in the country, successfully recycled more than six tons of material. Following this achievement, the company expanded the pilot to include additional departments within the hospital system to further validate the process and economic viability of this sustainability effort.

Key Market Players

• Hollister Incorporated
• B. Braun Medical, Inc.
• Terumo Corporation
• Coloplast Corp.
• C.R. Bard Inc.
• Kawasumi Laboratories Inc.
• Fresenius Medical Care AG & Co. KGaA
• Baxter International Inc.
• Convatec Group plc
• Westfield Medical Ltd.

By Product	By Region
Ostomy Collection Bags Intravenous (IV) Fluid Bags Continuous Ambulatory Peritoneal Dialysis (CAPD) Bags Resuscitation Bags Urinary Collection Bags Sterile Packaging Bags Anesthesia Breathing Bags Cadaver (Body) Bags Blood Bags Enema Bags Enteral Feeding Bags Bile Collection Bags Ice Bags	North America Europe Asia Pacific South America Middle East & Africa

Report Scope:

In this report, the Global Medical Specialty Bags Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Medical Specialty Bags Market, By Product:

• Ostomy Collection Bags
• Intravenous (IV) Fluid Bags
• Continuous Ambulatory Peritoneal Dialysis (CAPD) Bags
• Resuscitation Bags
• Urinary Collection Bags
• Sterile Packaging Bags
• Anesthesia Breathing Bags
• Cadaver (Body) Bags
• Blood Bags
• Enema Bags
• Enteral Feeding Bags
• Bile Collection Bags
• Ice Bags

• Medical Specialty Bags Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE